Can You Get Mounjaro If You're Not Overweight? The Licensing Reality

Mounjaro's UK licence for weight management requires a BMI of 30 or higher, or 27 or higher with at least one qualifying weight-related condition.
Using tirzepatide without a clinical indication is not appropriate — the MHRA is clear that GLP-1 medicines are not intended for cosmetic or minor weight loss.
For some ethnic backgrounds, UK guidance applies BMI thresholds that are 2.5 kg/m² lower, a prescriber will explain whether this applies to you.
A GPhC-registered Independent Prescriber personally reviews every consultation at nume before any prescription is issued.

Mounjaro is not licensed for people who are a healthy weight. To be prescribed tirzepatide for weight management in the UK, you need a BMI of 30 or above, or a BMI of at least 27 alongside a weight-related health condition such as high blood pressure or type 2 diabetes. A prescriber reviews every case individually, and BMI alone is not the final word — your full clinical picture matters. Mounjaro is a prescription-only medicine, so clinical assessment is required before any prescription can be issued.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the UK licence actually says, and why it matters for your situation

The misconception worth clearing up first

A lot of people arrive at this question after reading social media posts about Mounjaro producing dramatic results, and they wonder whether a few kilograms above their personal ideal weight would be enough to qualify. It's an understandable thought, and it's worth addressing honestly rather than dismissing it.

Mounjaro (tirzepatide) is licensed in the UK for adults with a BMI of 30 or higher, or a BMI of at least 27 where a weight-related condition is already present, conditions such as high blood pressure, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea. If your BMI sits below those thresholds and you don't have one of those conditions, tirzepatide is not licensed for your situation. That's not a policy decision by any particular clinic; it's what the medicine's UK authorisation covers, and it exists because the clinical trials that established the medicine's safety and effectiveness enrolled people within those parameters. The NHS medicines page for tirzepatide sets this out plainly.

The MHRA has also said publicly that GLP-1 medicines are not assessed or intended for quick or cosmetic weight loss. Prescribing outside licensed indications would require the prescriber to take on significant clinical and legal responsibility, most will not do so, and at nume they do not. Knowing this upfront saves a lot of time and disappointment.

Where the BMI thresholds actually sit, and the nuances that change things

The 30 and 27 figures are the headline numbers, but there are details worth understanding before you conclude you don't qualify.

First, the 27-plus-condition route is broader than people realise. If your BMI is, say, 28 and your GP has documented high cholesterol or borderline blood pressure, you may well sit within the licensed criteria. Our page on whether a BMI of 27 qualifies for Mounjaro explores that boundary in more detail.

Second, ethnic-background thresholds. UK guidance recognises that BMI can underestimate health risk for South Asian, Chinese, Middle Eastern, Black African, and African-Caribbean backgrounds. For those groups, thresholds are typically 2.5 kg/m² lower, meaning 27.5 instead of 30, or 24.5 instead of 27. A prescriber considers this during assessment. More on what the numbers mean in practice is covered on our Mounjaro BMI eligibility page.

Third, BMI is a starting point, not the whole picture. A prescriber looks at your weight history, any related conditions, current medications, and overall health before reaching a decision. Two people with the same BMI can have very different clinical profiles. You can also use the NHS BMI calculator to check where your reading sits before starting a consultation.

What happens if you're just below the threshold

If your BMI is close to 27 but not quite there, or sits between 27 and 30 without a documented weight-related condition, a legitimate prescriber will not issue a Mounjaro prescription. This is the right outcome, not a bureaucratic obstacle.

It is also worth knowing that a prescriber at a registered pharmacy cannot simply take your word for your weight. At nume, weight is verified on a live video call as part of every consultation, and if you are wondering whether you can take Mounjaro earlier than 7 days into a dosing interval, that same clinical oversight applies to questions like this too. Details of what a legitimate process looks like are on our guide to obtaining Mounjaro for weight loss.

If you're not currently eligible, the honest answer is that lifestyle changes (and, where appropriate, a conversation with your GP) are the right starting point. Mounjaro's licensed purpose is to support clinically significant weight loss in people for whom excess weight is already affecting health. The NHS healthy weight guidance is a good place to start if your situation doesn't yet meet the threshold.

How nume approaches eligibility at the free consultation

During a nume consultation, our GPhC-registered Independent Prescribers (real clinicians, not automated software) assess every application against the licensed criteria. If you meet them, your case moves forward the same day. If you don't, you'll get a clear explanation of why, and what alternatives might be appropriate.

The consultation is free and carries no obligation. There's no pressure to proceed, and no charge if you're found not to be suitable. We think that's how it should work for any prescription medicine.

If you're unsure where you stand on BMI, the overview of how much excess weight is needed for Mounjaro covers the licensed criteria in full. For a broader look at what private weight-loss treatment involves, our weight-loss treatment overview is a good starting point. Cost context, including what a private prescription typically includes, is covered on our Mounjaro pricing page.

If you think you do meet the criteria and want a prescriber to assess your case, start your free consultation here.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions